Jeffrey Rathmell, PhD
Dr. Rathmell studies mechanisms by which extracellular cues influence lymphocyte death and differentiation in efforts to control inflammatory diseases and leukemia. Following undergraduate studies on Biology at the University of Northern Iowa, he earned a Ph.D in Immunology on B cell tolerance and death mechanisms at Stanford University. In postdoctoral studies at the University of Chicago and University of Pennsylvania, he showed that lymphocyte metabolism was dynamically regulated by growth factors and controls apoptotic mechanisms. He began at Duke University in 2003 in the departments of Pharmacology and Cancer Biology and Immunology, as well as a member of the Duke Molecular Physiology Institute. Dr. Rathmell's group showed that the metabolism of T cells is highly dynamic and that specific metabolic programs are essential for each functional T cell subsets. These fundamental metabolic distinctions may now allow modulation of selective populations of lymphocytes in inflammatory diseases and anti-tumor immunity. He joined the faculty of Vanderbilt University in 2015 as Professor of Pathology, Microbiology, and Immunology to direct the Vanderbilt Center for Immunobiology and co-lead the Vanderbilt Ingram Cancer Center Host Tumor Interactions Program. He is Associate Director of the Vanderbilt Institute of Infection, Immunology, and Inflammation and co-leader of the Molecular Pathology and Immunology Ph.D training program.
Katy Beckermann, M.D./Ph.D.
Frank Mason, Ph.D.
Xiang Ye, Ph.D
Current Post-Doctoral Fellows
Gabriela Andrejeva, Ph.D., PMI
Current Graduate Students
Marc Johnson Pharmacology (Duke)
Diana Contreras Microbiology and Immunology (Vanderbilt)
Stephanie Dudzinski MSTP student
Ayaka Sugiura MSTP student
Matt Madden MSTP student
Dalton Greenwood MPI
Past Post-Doctoral Fellows
Nancie MacIver, M.D./Ph.D.
Assistant Professor (tenure track) Duke University, Pediatric Endocrinology
Liza Makowski, Ph.D.
Assistant Professor (tenure track) University of North Carolina at Chapel Hill, Nutrition
Ryan Michalek, Ph.D.
Senior Study Director, Metabolon Inc., Durham, NC
Pankuri Goraska-Hicks, Ph.D.
Director of Oncology Studies, Gentris
Alfredo Caro-Maldonado, Ph.D.
Post-doctoral Researcher, CIC BioGUNE, Spain
Andrew Macintyre, Ph.D.
Education and Professional Development Manager at American Society for Biochemistry and Molecular Biology (ASBMB)
Peter Siska, M.D.
Hematology-Oncology fellow at University Hospital Regensburg
Sivan Cohen, Ph.D.
Scientist, Genentech, San Francisco, CA
Past Graduate Students
Pharm Defended PhD 11/29/2007
Current Clinical Scientist-Drug Development, Aratana Therapeutics, Kansas City, MO
Pharm Defended PhD 12/6/2007
Currently a Police Officer, Melbourne Australia.
MCB Defended PhD 04/08
Senior Scientist, ZenBio, Research Triangle Park, NC
IMM Defended M.S. 2009
Associate Veterinarian at United Veterinary Specialty and Emergency, San Francisco
MCB Defended PhD 11/09
Current Post-doc with Blossom Damania at UNC Chapel Hill
Emily F Mason
MCB/MSTP Defended PhD 7/10
Assistant Professor at Vanderbilt University, Department of Pathology
Pharm Defended PhD 9/10
Post-doc with Joan Brugge at Harvard Univeristy
Brian J. Altman
MCB Defended PhD 5/11
Post-doc with Chi Dang, University of Pennsylvania
Valerie A. Gerriets
Pharm Defended PhD 2/21/14
Assistant Professor of Pharmacology, California Northstate University College of Medicine
Pharm Defended PhD 10/20/14
Post-doc with Jeffrey Engelman, Harvard University
Pharm Defended PhD 05/09/2016
Post-doc with Nick Restifo, National Cancer Institute (Surgery Branch)